Side effects include:
Bleeding (, ecchymoses, GI bleeding, intracranial hemorrhage).
The most common side effect associated with drotrecogin alfa has been bleeding.
Hematologic side effects have most commonly included bleeding ( vs  with placebo).
The majority of events were ecchymoses or gastrointestinal tract bleeding.
Serious bleeding has been reported in  of patients (vs  with placebo) and included intracranial hemorrhage, life threatening hemorrhage, and any event requiring  or more units of packed red blood cells per days for  consecutive days.
Serious bleeding events have been reported at the following sites:  Gastrointestinal, intra-abdominal, intrathoracic, retroperitoneal, intracranial, genitourinary, skin or soft tissues.